Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Populationbased Study on Pancreatic Cancer in Stockholm- Mutation Profiling Characteristics, Biobanking and Risk Factors.

NCT02162823 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT02162823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02162823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Populationbased Study on Pancreatic Cancer in Stockholm- Mutation Profiling Characteristics, Biobanking and Risk Factors.
Lead sponsor
Karolinska University Hospital
Phase
Observational
Overall status
Completed
Start date
May 31, 2007
Completion date
February 28, 2017
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer